Jump to content
predictibd.dkPeople

Tine Jess - Professor, MD, DMSc

Director of Center for Molecular Prediction of Inflammatory Bowel Disease – PREDICT

LinkedIn

Tine Jess - Professor, MD, DMSc

Director of Center for Molecular Prediction of Inflammatory Bowel Disease – PREDICT

LinkedIn

Professor Tine Jess is an international expert in the field of inflammatory bowel disease (IBD). At age 33, she defended her doctoral thesis on prognosis of IBD from Denmark and the Mayo Clinic, US. Alongside, she was co-responsible for creation of a Department of Epidemiology at Novo Nordisk A/S. At age 35, she received a Female Research Leader Grant from the Danish Council of Independent Research and ran a large and successful research group in Copenhagen during 2010-2016, with numerous important contributions to the field published in Gastroenterology, Gut, BMJ, JAMA and New England Journal of Medicine. At age 39, she became professor of Gastroenterology and Epidemiology, and in later years, she has headed Center for Clinical Research and Prevention in the Capital Region of Denmark and Department of Epidemiology Research at Statens Serum Institut in Copenhagen.

Tine Jess is Fellow of the Royal Danish Academy of Science and Letters, has received the UNESCO For Women in Science Award, the UEGW Rising Star Award, a Danish Medal of Honor, she has served as Vice Chair of the Young Academy of the Royal Danish Society of Science and Letters, Head of the Epidemiological Committee of the European Crohn Colitis Organization, member of the ministerial Task Force working to increase the number of women in science, InnoWoman for Innovation Fund Denmark, and Chair of the Board of 'Selskab for Teoretisk og Anvendt Terapi af 1923'. 

She is a member of the Danish Council for Research and Innovation Policy, DFiR (2023-2026), appointed by the Danish Minister for Higher Education and Science; member of the Scientific Advisory Board of the Cluster of Excellence ‘Precision Medicine in Chronic Inflammation’ (PMI), Christian-Albrechts-Universität zu Kiel, Germany; and member of the Scientific Advisory Board Biocluster Eurosanté 2030 (French government’s Health Innovation Plan 2030).